Back to Search
Start Over
Medarex/MedImmune begin dosing in Ph I MEDI-545 trial
- Source :
- Pharma Marketletter. April 24, 2006
- Publication Year :
- 2006
-
Abstract
- Medarex says that its partner, fellow US drugmaker MedImmune, has begun dosing patients in a Phase I clinical trial of MEDI-545 for the potential treatment of systemic lupus erythematosus. The [...]
- Subjects :
- MedImmune L.L.C. -- Alliances and partnerships
MedImmune L.L.C. -- Product development
Biopharmaceutics -- Product development
Pharmaceutical industry -- Alliances and partnerships
Pharmaceutical industry -- Product development
Lupus erythematosus -- Drug therapy
Cooperative agreement for product development
Pharmaceuticals and cosmetics industries
Subjects
Details
- Language :
- English
- ISSN :
- 13558501
- Database :
- Gale General OneFile
- Journal :
- Pharma Marketletter
- Publication Type :
- News
- Accession number :
- edsgcl.144776814